Åڹ̻縣ź(Telmisartan) ½ÃÀå : Á¶¼ºº°, ÀûÀÀÁõº°, Á¦Çüº°, À¯Åë ä³Îº°, Áö¿ªº°
Telmisartan Market, By Composition, By Indication, By Dosage Form, By Distribution Channel, By Geography
»óǰÄÚµå : 1672928
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,640,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Åڹ̻縣ź ¼¼°è ½ÃÀåÀº 2025³â¿¡ 43¾ï 6,000¸¸ ´Þ·¯, 2032³â¿¡´Â 57¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 43¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 3.90% 2032³â ±Ý¾× ¿¹Ãø 57¾ï 1,000¸¸ ´Þ·¯
±×¸². Åڹ̻縣ź ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº° ½ÃÀå Á¡À¯À²
Telmisartan Market-IMG1

Åڹ̻縣źÀº ¾ÈÁö¿ÀÅٽŠII ¼ö¿ëü ±æÇ×Á¦·Î, ÁÖ·Î °íÇ÷¾Ð°ú ´ç´¢º´¼º ½ÅÁõ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. Ç÷°ü ÆòȰ±Ù°ú ºÎ½Å¿¡ Á¸ÀçÇÏ´Â AT1 ¼ö¿ëü¿¡ ¾ÈÁö¿ÀÅٽŠII°¡ °áÇÕÇÏ´Â °ÍÀ» ¼±ÅÃÀûÀ¸·Î ¾ïÁ¦ÇÏ¿© ÀÛ¿ëÇÕ´Ï´Ù. Åڹ̻縣źÀº ¾ÈÁö¿ÀÅٽŠIIÀÇ Ç÷°ü ¼öÃà ÀÛ¿ë°ú ¾Ëµµ½ºÅ×·Ð ºÐºñ ÀÛ¿ëÀ» ¾ïÁ¦ÇÏ¿© Ç÷¾ÐÀ» ³·Ãä´Ï´Ù. Åڹ̻縣źÀº °æ±¸¿ë ÀǾàǰÀ¸·Î ´Ù¾çÇÑ »óǰ¸íÀ¸·Î ÆÇ¸ÅµÇ°í ÀÖÀ¸¸ç, Àå±â°£ÀÇ ÀÓ»ó½ÃÇèÀ» ÅëÇØ ¾ÈÀü¼ºÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ½ÉÇ÷°ü °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °íÇ÷¾Ð À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è Åڹ̻縣ź ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

Åڹ̻ìź ¼¼°è ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ±Þ¼ÓÇÑ °í·ÉÈ­, Àü ¼¼°è °íÇ÷¾Ð À¯º´·ü Áõ°¡, ºñ¸¸À¸·Î ÀÎÇÑ ÁÂ½Ä »ýȰ½À°ü Áõ°¡, ½ÅÈï±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ºÐ¼®µË´Ï´Ù. ±×·¯³ª Á¦³×¸¯ ÀǾàǰÀÇ ´ëü °¡´É¼º°ú ÁÖ¿ä ºê·£µåÀÇ Æ¯Çã ¸¸·á´Â ½ÃÀå °ü°èÀڵ鿡°Ô µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Åڹ̻ìźÀÇ Ä¡·á ¿ëµµ¸¦ È®´ëÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸¿Í °íÇ÷¾Ð ÀÌ¿ÜÀÇ Áúȯ¿¡ ´ëÇÑ È¿´ÉÀ» Æò°¡Çϱâ À§ÇØ ÁøÇà ÁßÀÎ ÀÓ»ó½ÃÇèÀº °¡±î¿î ½ÃÀÏ ³»¿¡ ÀÌÇØ°ü°èÀڵ鿡°Ô ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹ÀÇ ÇöÁö À¯Åë ³×Æ®¿öÅ©¿ÍÀÇ Á¦ÈÞ´Â ¹ÌÃæÁ· ¼ö¿ä¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ´Â ¸Å·ÂÀûÀÎ ¼ö´ÜÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Åڹ̻縣ź ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Åڹ̻縣ź ½ÃÀå, Á¶¼ºº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦6Àå Åڹ̻縣ź ¼¼°è ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦7Àå Åڹ̻縣ź ¼¼°è ½ÃÀå, Á¦Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ Åڹ̻縣ź ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ Åڹ̻縣ź ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Telmisartan Market is estimated to be valued at USD 4.36 Bn in 2025 and is expected to reach USD 5.71 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.36 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 3.90% 2032 Value Projection: USD 5.71 Bn
Figure. Telmisartan Market Share (%), By Region 2025
Telmisartan Market - IMG1

Telmisartan is an angiotensin II receptor antagonist that is used primarily in the treatment of hypertension and diabetic nephropathy. It works by selectively blocking the binding of angiotensin II to the AT1 receptors present in vascular smooth muscle and the adrenal glands. By blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II, telmisartan helps lower blood pressure. It is available under various brand names as an oral medication and has a well-established safety profile supported by long-term clinical trials. Growing awareness about cardiovascular health and increasing prevalence of hypertension can drive the global telmisartan market growth.

Market Dynamics:

Global telmisartan market growth is driven by factors such as rapidly aging population, rising prevalence of hypertension worldwide, increasing adoption of sedentary lifestyle resulting in obesity, and growing healthcare expenditure in emerging nations. However, availability of generic substitutes and patent expiration of major brands can pose challenges for market players. Continuous research on expanding therapeutic applications of telmisartan and ongoing clinical trials evaluating its efficacy in treatment of conditions beyond hypertension can offer opportunities for stakeholders in the near future. Partnerships with local distribution networks in developing countries also provide an attractive avenue for leveraging unmet demand.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Telmisartan Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Telmisartan Market, By Composition, 2020 - 2032, (USD Bn)

6. Global Telmisartan Market, By Indication 2020 - 2032, (USD Bn)

7. Global Telmisartan Market, By Dosage Form, 2020 - 2032, (USD Bn)

8. Global Telmisartan Market, By Distribution Channel 2020 - 2032, (USD Bn)

9. Global Telmisartan Market, By Region, 2020 - 2032, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â